Association of TaqIB polymorphism in the cholesteryl ester transfer protein gene with serum lipid levels in the Guangxi Hei Yi Zhuang and Han populations

Journal of Investigative Medicine

Volumn 56, Issue 6, 2008, Pages 847-857

  Zhou, Yijiang ^a,b   Yin, Ruixing ^a   Li, Yiyang ^a   Deng, Yaju ^a   Pan, Shangling ^c   Lin, Weixiong ^a   Yang, Dezhai ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b Department of Cardiology   (China)

^c Department of Pathophysiology   (China)

Author keywords

Apolipoproteins; Cholesteryl ester transfer protein; Gene; Lipids; Polymorphism

Indexed keywords

CETP PROTEIN, HUMAN; CHOLESTEROL ESTER TRANSFER PROTEIN; DNA; LIPID; TCGA SPECIFIC TYPE II DEOXYRIBONUCLEASES; TCGA-SPECIFIC TYPE II DEOXYRIBONUCLEASES; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; ASIAN; BLOOD; CHINA; FEMALE; GENE FREQUENCY; GENETICS; HUMAN; MALE; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADOLESCENT; ADULT; AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; CHINA; CHOLESTEROL ESTER TRANSFER PROTEINS; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DNA; FEMALE; GENE FREQUENCY; HUMANS; LIPIDS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 53449083575     PISSN: 17088267     EISSN: 17088267     Source Type: Journal    
DOI: 10.2310/jim.0b013e3181820832     Document Type: Article

References (64)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
2. Satoh H, Nishino T, Tomita K, et al. Fasting triglyceride is a significant risk factor for coronary artery disease in middle-aged Japanese men: results from a 10-year cohort study. Circ J. 2006;70:227-231.
3. Achari V, Thakur AK. Association of major modifiable risk factors among patients with coronary artery disease - a retrospective analysis. J Assoc Physicians India. 2004;52: 103-108.
4. Kwiterovich PO Jr, Coresh J, Smith HH, et al. Comparison of the plasma levels of apolipoproteins B and A-1, and other risk factors in men and women with premature coronary artery disease. Am J Cardiol. 1992;69: 1015-1021.
5. Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 1989;79:8-15.
6. Sharrett AR, Ballantyne CM, Coady SA, et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions. Circulation. 2001;104:1108-1113.
7. Heller DA, de Faire U, Pedersen NL, et al. Genetic and environmental influences on serum lipid levels in twins. N Engl J Med. 1993;328:1150-1156.
8. Brousseau ME, O'Connor JJ Jr, Ordovas JM, et al. Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency. Arterioscler Thromb Vasc Biol. 2002;22: 148-1154.
9. Bruce C, Chouinard RA Jr, Tall AR. Plasma lipid transfer proteins, high density lipoproteins, and reverse cholesterol transport. Annu Rev Nutr. 1998;18:297-330.
10. Barter PJ, Rye KA. High density lipoproteins and coronary artery disease. Atherosclerosis. 1996;121:1-12.
11. Drayna D, Jarnagin AS, McLean J, et al. Cloning and sequencing of human cholesteryl ester transfer protein cDNA. Nature. 1987;327:632-634.
12. Agellon LB, Quinet EM, Gillette TG, et al. Organization of the human cholesteryl ester transfer protein gene. Bio chemistry. 1990;29:1372-1376.
13. Tall AR. Plasma lipid transfer proteins. J Lipid Res. 1986;27:361-367.
14. Zheng K, Zhang S, Zhang L, et al. Carriers of three polymorphisms of cholesteryl ester transfer protein gene are at increased risk to coronary heart disease in a Chinese population. Int J Cardiol. 2005;103:259-265.
15. Nagano M, Nakamura M, Kobayashi N, et al. Effort angina in a middle-aged woman with abnormally high levels of serum high-density lipoprotein cholesterol: a case of cholesteryl-ester transfer protein deficiency. Circ J. 2005;69:609-612.
16. Blankenberg S, Tiret L, Bickel C, et al. Genetic variation of the cholesterol ester transfer protein gene and the prevalence of coronary artery disease. The AtheroGene case control study. Z Kardiol. 2004;93:16-23.
17. Agerholm-Larsen B, Tybjaerg-Hansen A, Schnohr P, et al. Common cholesteryl ester transfer protein mutations, decreased HDL cholesterol, and possible decreased risk of ischemic heart disease. The Copenhagen City Heart Study. Circulation. 2000;102:2197-2203.
18. Frisdal E, Klerkx AH, Le Goff W, et al. Functional interaction between -629C/A, -71G/A and -1337C/T polymorphisms in the CETP gene is a major determinant of promoter activity and plasma CETP concentration in the REGRESS Study. Hum Mol Genet. 2005;14:2607-2618.
19. Freeman DJ, Packard CJ, Shepherd J, et al. Polymor phisms in the gene coding for cholesteryl ester transfer protein are related to plasma high-density lipoprotein cholesterol and transfer protein activity. Clin Sci. 1990; 79:575-581.
20. Kondo I, Berg K, Drayna D, et al. DNA polymorphism at the locus for human cholesteryl ester transfer protein (CETP) is associated with high density lipoprotein cholesterol and apolipoprotein levels. Clin Genet. 1989; 35:49-56.
21. McPherson R, Grundy SM, Guerra R, et al. Allelic variation in the gene encoding the cholesteryl ester transfer protein is associated with variation in the plasma concentrations of cholesteryl ester transfer protein. J Lipid Res. 1996;37:1743-1748.
22. Arai H, Yamamoto A, Matsuzawa Y, et al. Polymorphisms in four genes related to triglyceride and HDL-cholesterol levels in the general Japanese population in 2000. J Atheroscler Thromb. 2005;12:240-250.
23. Ordovas JM, Cupples LA, Corella D, et al. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk. Arterioscler Thromb Vasc Biol. 2000;20: 1323-1329.
24. Crella D, Saiz C, Guillén M, et al. Association of TaqIB polymorphism in the cholesteryl ester transfer protein gene with plasma lipid levels in a healthy Spanish population. Atherosclerosis. 2000;152:367-376.
25. Cuchel M, Wolfe ML, deLemos AS, et al. The frequency of the cholesteryl ester transfer protein-TaqI B2 allele is lower in African Americans than in Caucasians. Athero sclerosis. 2002;163:169-174.
26. Arca M, Montali A, Ombres D, et al. Lack of association of the common TaqIB polymorphism in the cholesteryl ester transfer protein gene with angiographically assessed coronary atherosclerosis. Clin Genet. 2001;60:374-380.
27. Sy RG, Cutiongco EM, Punzalan FE, et al. Human cholesteryl ester transfer protein (TaqIB) polymorphism among Filipinos with cardiovascular risk factors. J Atheroscler Thromb. 2007;14:116-121.
28. Tenkanen H, Koshinen P, Kontula K, et al. Polymorphisms of the gene encoding cholesterol ester transfer protein and serum lipoprotein levels in subjects with and without coronary heart disease. Hum Genet. 1991;87:574-578.
29. Mitchell RJ, Earl L, Williams J, et al. Polymorphisms of the gene coding for the cholesteryl ester transfer protein and plasma lipid levels in Italian and Greek migrants to Australia. Hum Biol. 1994;66:13-25.
30. Fumeron F, Betoulle D, Luc G, et al. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J Clin Invest. 1995;96:1664-1671.
31. Kauma H, Savolainen MJ, Heikkila R, et al. Sex difference in the regulation of plasma high density lipoprotein cholesterol by genetic and environmental factors. Hum Genet. 1996;97:156-162.
32. Hannuksela ML, Liinamaa MJ, Kesaniemi YA, et al. Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers. Atherosclerosis. 1994;110:35-44.
33. Freeman DJ, Griffin BA, Holmes AP, et al. Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors. Associations between the TaqI B RFLP in the CETP gene and smoking and obesity. Arterioscler Thromb. 1994;14:336-344.
34. Vohl MC, Lamarche B, Pascot A, et al. Contribution of the cholesteryl ester transfer protein gene TaqIB polymorphism to the reduced plasma HDL-cholesterol levels found in abdominal obese men with features of the insulin resistance syndrome. IntJ Obes Relat Metab Disord. 1999;23:918-925.
35. Yin R, Chen Y, Pan S, et al. Comparison of lipid levels, hyperlipidemia prevalence and its risk factors between Guangxi Hei Yi Zhuang and Han populations. Arch Med Res. 2006;37:787-793.
36. Ruixing Y, Fengbing H, Shangling P, et al. Prevalence of hyperlipidemia and its risk factors for the middle-aged and elderly in the Guangxi Hei Yi Zhuang and Han popula tions. J Investig Med. 2006;54:191-200.
37. Ruixing Y, Yuming C, Shangling P, et al. Effects of demographic, dietary, and other lifestyle factors on the prevalence of hyperlipidemia in Guangxi Hei Yi Zhuang and Han populations. Eur J Cardiovasc Prev Rehabil. 2006;13:977-984.
38. Ruixing Y, Rongshan L, Weixiong L, et al. Effect of the MTP-493 G/T polymorphism on the lipid profiles of the Guangxi Hei Yi Zhuang and Han populations. Eur J Lipid Sci Technol. 2006;108:561-568.
39. Ruixing Y, Guangqin C, Yong W, et al. Effect of the 3'APOB-VNTR polymorphism on the lipid profiles in the Guangxi Hei Yi Zhuang and Han populations. BMC Med Genet. 2007;8:45-58.
40. Yin R, Wang Y, Chen G, et al. Lipoprotein lipase gene polymorphism at the PvuII locus and serum lipid levels in Guangxi Hei Yi Zhuang and Han populations. Clin Chem Lab Med. 2006;44:1416-1421.
41. People's Republic of China - United States Cardiovascular and Cardiopulmonary Epidemiology Research Group. An epidemiological study of cardiovascular and cardiopulmonary disease risk factors in four populations in the People's Republic of China. Baseline report from the P.R.C.-U.S.A. Collaborative Study. Circulation. 1992;85: 1083-1096.
42. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.
43. Ruixing Y, Limei Y, Yuming C, et al. Prevalence, awareness, treatment, control and risk factors of hypertension in the Guangxi Hei Yi Zhuang and Han populations. Hypertens Res. 2006;29:423-432.
44. Ruixing Y, Jiaqiang D, Dezhai Y, et al. Effects of demographic characteristics, health-related behaviors and lifestyle factors on the prevalence of hypertension for the middle-aged and elderly in the Guangxi Hei Yi Zhuang and Han Populations. Kidney Blood Press Res. 2006;29: 312-320.
45. Cooperative Meta-analysis Group of China Obesity Task Force. Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Chin J Epidemiol. 2002;23:5-10.
46. Thu NN, Mai TT, Ohmori R, et al. Effect of the cholesteryl ester transfer protein genotypes on plasma lipid and lipoprotein levels in Vietnamese children. Pediatr Res. 2005;58:1249-1253.
47. Hong SH, Kim YR, Song J, et al. Genetic variations of cholesterol ester transfer protein gene in Koreans. Hum Biol. 2001;73:815-821.
48. Hsu LA, Ko YL, Hsu KH, et al. Genetic variations in the cholesteryl ester transfer protein gene and high density lipoprotein cholesterol levels in Taiwanese Chinese. Hum Genet. 2002;110:57-63.
49. Meguro S, Takei I, Murata M, et al. Cholesteryl ester transfer protein polymorphism associated with macroangiopathy in Japanese patients with type 2 diabetes. Atherosclerosis. 2001;156:151-156.
50. Miltiadous G, Hatzivassiliou M, Liberopoulos E, et al. Gene polymorphisms affecting HDL-cholesterol levels in the normolipidemic population. Nutr Metab Cardiovasc Dis. 2005;15:219-224.
51. Boekholdt SM, Sacks FM, Jukema JW, et al. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation. 2005;111:278-287.
52. Boekholdt SM, Kuivenhoven JA, Wareham NJ, et al. Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women: The Prospective EPIC (European Pro spective Investigation into Cancer and nutrition) - Norfolk Population Study. Circulation. 2004;110:1418-1423.
53. Tsujita Y, Nakamura Y, Zhang Q, et al. The association between high-density lipoprotein cholesterol level and cholesteryl ester transfer protein TaqIB gene polymorphism is influenced by alcohol drinking in a population-based sample. Atherosclerosis. 2007;191:199-205.
54. Hodoglugil U, Williamson DW, Huang Y, et al. An interaction between the TaqIB polymorphism of cholester ol ester transfer protein and smoking is associated with changes in plasma high-density lipoprotein cholesterol levels in Turks. Clin Genet. 2005;68:118-127.
55. Park KW, Choi JH, Kim HK, et al. The association of cholesteryl ester transfer protein polymorphism with high-density lipoprotein cholesterol and coronary artery disease in Koreans. Clin Genet. 2003;63:31-38.
56. Freeman DJ, Samani NJ, Wilsona V, et al. A polymorph ism of the cholesteryl ester transfer protein gene predicts cardiovascular events in non-smokers in the West of Scotland Coronary Prevention Study. Eur Heart J. 2003; 24:1833-1842.
57. Dong W, Ma X, Zhang D, et al. Effect of maize embryo on delaying aging. Food Sci. 2002;23:95-97.
58. Lairon D. Dietary fibres: effects on lipid metabolism and mechanisms of action. Eur J Clin Nutr. 1996;50: 125-133.
59. Yu-Poth S, Zhao G, Etherton T, et al. Effects of National Cholesterol Education Program's Step I and Step II dietary intervention programs on cardiovascular disease risk factors: a meta-analysis. Am J Clin Nutr. 1999;69:632-646.
60. Huttunen JK, Lansimies E, Voutilainen E, et al. Effect of moderate physical exercise on serum lipoproteins. A controlled clinical trial with special reference to serum high-density lipoproteins. Circulation. 1979;60:1220-1229.
61. Durstine JL, Haskell WL. Effects of exercise training on plasma lipids and lipoproteins. Exerc Sport Sci Rev. 1994; 22:477-521.
62. Bouchard C, Rankinen T. Individual differences in response to regular physical activity. Med Sci Sports Exerc. 2001;33:S446-S451.
63. Leon AS, Rice T, Mandel S, et al. Blood lipid response to 20 weeks of supervised exercise in a large biracial population: the HERITAGE Family Study. Metabolism. 2000;49:513-520.
64. Leon AS, Gaskill SE, Rice T, et al. Variability in the response of HDL cholesterol to exercise training in the HERITAGE Family Study. Int J Sports Med. 2002;23:1-9.